HK

Harpreet Kaur

Active Director Director DIN 09117675
DIN 09117675 First appointment Mar 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Mar 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Harpreet Kaur

Data last updated:

Harpreet Kaur is a Director at Chirron Meditek Devices Private Limited (since 2025) and Designated Partner at Chirron Meditek Llp (since 2021). The companies operate in Healthcare.

DIN 09117675
Primary Designation Director
Industry Healthcare
First Appointment 22 Mar 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Oct 20252025Active
Designated Partner22 Mar 20212021Active

Board colleagues of Harpreet Kaur

Directorship timeline

Open interactive timeline →
Chirron Meditek Llp
Chirron Meditek Devices Private Limited
Premium access

Shareholding and investment profile for Harpreet Kaur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Harpreet Kaur

Harpreet Kaur currently holds 2 directorships: Chirron Meditek Devices Private Limited (Director, since 30 Oct 2025); Chirron Meditek Llp (Designated Partner, since 22 Mar 2021).

Harpreet Kaur was first appointed on 22 Mar 2021 as Designated Partner at Chirron Meditek Llp. The most recent appointment on record is 30 Oct 2025 at Chirron Meditek Devices Private Limited.

The current boards of Harpreet Kaur's companies include Vikas Gupta (Chirron Meditek Devices Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available